BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 17369190)

  • 1. CD4+CD25+ regulatory T cells are activated in vivo by recognition of self.
    Andersson J; Stefanova I; Stephens GL; Shevach EM
    Int Immunol; 2007 Apr; 19(4):557-66. PubMed ID: 17369190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In-vitro generation and characterisation of murine CD4+CD25+ regulatory T cells with indirect allospecificity.
    Tsang J; Jiang S; Tanriver Y; Leung E; Lombardi G; Lechler RI
    Int Immunopharmacol; 2006 Dec; 6(13-14):1883-8. PubMed ID: 17161341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nonantigen specific CD8+ T suppressor lymphocytes originate from CD8+CD28- T cells and inhibit both T-cell proliferation and CTL function.
    Filaci G; Fravega M; Negrini S; Procopio F; Fenoglio D; Rizzi M; Brenci S; Contini P; Olive D; Ghio M; Setti M; Accolla RS; Puppo F; Indiveri F
    Hum Immunol; 2004 Feb; 65(2):142-56. PubMed ID: 14969769
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD4+ CD25+ [corrected] regulatory T cells render naive CD4+ CD25- T cells anergic and suppressive.
    Qiao M; Thornton AM; Shevach EM
    Immunology; 2007 Apr; 120(4):447-55. PubMed ID: 17244157
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of CD4+ CD25+ regulatory T cell suppressor function by analogs of the selecting peptide.
    Larkin J; Picca CC; Caton AJ
    Eur J Immunol; 2007 Jan; 37(1):139-46. PubMed ID: 17154263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Active CD4+ helper T cells directly stimulate CD8+ cytotoxic T lymphocyte responses in wild-type and MHC II gene knockout C57BL/6 mice and transgenic RIP-mOVA mice expressing islet beta-cell ovalbumin antigen leading to diabetes.
    Ye Z; Ahmed KA; Hao S; Zhang X; Xie Y; Munegowda MA; Meng Q; Chibbar R; Xiang J
    Autoimmunity; 2008 Nov; 41(7):501-11. PubMed ID: 18855194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High antigen dose and activated dendritic cells enable Th cells to escape regulatory T cell-mediated suppression in vitro.
    George TC; Bilsborough J; Viney JL; Norment AM
    Eur J Immunol; 2003 Feb; 33(2):502-11. PubMed ID: 12645949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased numbers and suppressive activity of regulatory CD25(+)CD4(+) T lymphocytes in the absence of CD4 engagement by MHC class II molecules.
    Shen X; Niu C; König R
    Cell Immunol; 2013 Apr; 282(2):117-28. PubMed ID: 23770721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antigen-specific recognition is critical for the function of regulatory CD8(+)CD28(-) T cells.
    Renner P; Popp FC; Eggenhofer E; Slowik P; Piso P; Geissler EK; Schlitt HJ; Dahlke MH
    Transpl Immunol; 2010 Feb; 22(3-4):144-9. PubMed ID: 19840851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD8+ memory T cells (CD44high, Ly-6C+) are more sensitive than naive cells to (CD44low, Ly-6C-) to TCR/CD8 signaling in response to antigen.
    Curtsinger JM; Lins DC; Mescher MF
    J Immunol; 1998 Apr; 160(7):3236-43. PubMed ID: 9531279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of CD25-positive T cells during syngeneic pregnancy: production of stimulatory class II MHC molecules.
    Kyvelidou C; Chatzi K; Semitekolou M; Papathanassiou X; Vassiliadis S; Athanassakis I
    Scand J Immunol; 2009 Dec; 70(6):584-95. PubMed ID: 19906201
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD4-mediated functional activation of human CD4+CD25+ regulatory T cells.
    Becker C; Kubach J; Wijdenes J; Knop J; Jonuleit H
    Eur J Immunol; 2007 May; 37(5):1217-23. PubMed ID: 17407195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of bispecific heteroconjugated antibodies (anti-T cell antigen receptor x anti-MHC class II) to study activation of T cells with a full length or truncated antigen receptor zeta-chain.
    Wu S; Yang Y; Sadegh-Nasseri S; Ashwell JD
    J Immunol; 1993 Mar; 150(6):2211-21. PubMed ID: 8450208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tolerogenic semimature dendritic cells induce effector T-cell hyporesponsiveness by the activation of antigen-specific CD4+ CD25+ T-regulatory cells.
    Fu BM; He XS; Yu S; Hu AB; Ma Y; Wu LW; Tam NL; Huang JF
    Exp Clin Transplant; 2009 Sep; 7(3):149-56. PubMed ID: 19715524
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Large-scale expansion of rat CD4+ CD25+ T(reg) cells in the absence of T-cell receptor stimulation.
    Beyersdorf N; Balbach K; Hünig T; Kerkau T
    Immunology; 2006 Dec; 119(4):441-50. PubMed ID: 16903867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ex vivo activated OVA specific and non-specific CD4+CD25+ regulatory T cells exhibit comparable suppression to OVA mediated T cell responses.
    Li J; Bracht M; Shang X; Radewonuk J; Emmell E; Griswold DE; Li L
    Cell Immunol; 2006 Jun; 241(2):75-84. PubMed ID: 17010326
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential influence of the tumour-specific non-human sialic acid containing GM3 ganglioside on CD4+CD25- effector and naturally occurring CD4+CD25+ regulatory T cells function.
    de León J; Fernández A; Clavell M; Labrada M; Bebelagua Y; Mesa C; Fernández LE
    Int Immunol; 2008 Apr; 20(4):591-600. PubMed ID: 18310617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impaired function of dendritic cells in alymphoplasia (aly/aly) mice for expansion of CD25+CD4+ regulatory T cells.
    Tamura C; Nakazawa M; Kasahara M; Hotta C; Yoshinari M; Sato F; Minami M
    Autoimmunity; 2006 Sep; 39(6):445-53. PubMed ID: 17060023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IL-2 induces in vivo suppression by CD4(+)CD25(+)Foxp3(+) regulatory T cells.
    Brandenburg S; Takahashi T; de la Rosa M; Janke M; Karsten G; Muzzulini T; Orinska Z; Bulfone-Paus S; Scheffold A
    Eur J Immunol; 2008 Jun; 38(6):1643-53. PubMed ID: 18493984
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro expanded alloantigen-specific CD4+CD25+ regulatory T cell treatment for the induction of donor-specific transplantation tolerance.
    Jiang S; Golshayan D; Tsang J; Lombardi G; Lechler RI
    Int Immunopharmacol; 2006 Dec; 6(13-14):1879-82. PubMed ID: 17161340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.